Dr. NICOLAS DUHEM

Primary focus in biotechnology, pharmaceuticals, medical devices and health care insurance Med Tech acquisition; US Payor strategy; Biotech PE due diligence; Med Tech strategy; Pharma transformation

Ensured launch readiness plan and track overall preparation of regions, main affiliates and cross-functional for Rinvoq; Shaped the clinical trial program and evidence generation through cross-functional alignment (Clinical Development, Medical, Market Access, HEOR, US) to maximize access and Upadacitinib adoption at launch

Responsible of the implementation of competition strategy and tactics for Humira -Competitive Readiness: Help affilliates to improve their competitive readiness at the light of the current and upcoming new MOAS -Strategic Planning -Develop the Competitive Intelligence strategy -Coordination of international meetings

Define the Brand Strategy, develop operational and tactical plans to address the needs of all stakeholders, including enriching the patient experience in collaboration with the Brand Teams and the infield Teams and execute the marketing actions related. Role & responsabilities: - Patient Journey - Strategic Brand Planning - Implementation - Finance Forecasting and monitoring - Compliance

(i) Develop reimbursement dossiers based on medical, scientific and health-economic data in collaboration with the medical and marketing departments (ii) Submit and give the appropriate follow-up to these reimbursement files (iii) Develop and maintain the appropriate contacts in the therapeutic domain (opinion leaders and external experts) in order to secure the success of the reimbursement files

As a scientific project leader to develop innovative solutions for the administration of poorly soluble drugs and anticancer agents using nanotechnology.

Fianance/Entrepreneurship High Honors

Nanotechnology/Poorly Soluble Drugs/Chemotherapeutics

High Honors